blog.aids.gov − NIH
AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV - Changing to HIV.gov in Spring 2017

MENU

NIH

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

For Immediate Release: Friday, March 6, 2015 Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat…

NIH Funding Opportunity for Drug Abuse Prevention Research Holds Potential for Addressing Viral Hepatitis

The National Institute on Drug Abuse (NIDA), part of NIH, has released a Funding Opportunity Announcement (FOA) for research that will increase understanding of the science of drug use prevention within diverse populations and settings. Given the high prevalence of hepatitis C virus (HCV) infection among persons who inject drugs (PWID), this research also holds…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection….

Conversations from CROI 2015: Dr. Gina Brown and Dr. Ron Valdiserri on Microbicides, Women and HIV

As we approach the annual observance of National Women and Girls HIV/AIDS Awareness Day next week, we wanted to share another interview we captured at the 2015 Conference on Retroviruses and Opportunistic Infections  (CROI). While at CROI in Seattle last week, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, spoke with Dr. Gina…

Final CROI 2015 Highlights from NIH’s Dr. Carl Dieffenbach

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle came to a close on Thursday, February 26, we spoke again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) about a highlight from the day’s presentations as well as his reflections as the…

More CROI 2015 Highlights from NIH’s Dr. Carl Dieffenbach (Video)

After another day full of presentations on the latest in HIV science at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle yesterday, February 25, we had the opportunity to speak again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared…

NIH’s Dr. Carl Dieffenbach Shares Highlights from First Day of CROI 2015 (Video)

After the first full day of sessions at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle yesterday, February 24, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of…

NIH’s Dr. Carl Dieffenbach Shares Highlights as CROI 2015 Begins (Video)

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) got underway in Seattle yesterday, February 23, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He discussed what we can anticipate hearing more about during this annual scientific meeting that brings…